Earnings Per Share, Basic in USD/shares of Amylyx Pharmaceuticals, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Amylyx Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.37 USD/shares, a 65.4% increase year-over-year.
  • Amylyx Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 53.1% increase year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -4.43 USD/shares, a 707% decline from 2023.
  • Amylyx Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was 0.73 USD/shares.
  • Amylyx Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.39 USD/shares, a 74.6% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Amylyx Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 +$0.70 +65.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$2 $0 +$0.61 +57% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$3 $0 +$1.33 +76% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$4 -$1 -$1 -871% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-04
Q3 2024 -$3 -$1 -$1 -445% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$2 -$1 -$1 -424% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$1 -$2 -$2 -8850% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $0 $0.07 +$0.68 Oct 1, 2023 Dec 31, 2023 10-K 2025-03-04
Q3 2023 $0 $0.31 +$1.23 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1 $0.33 +$1.26 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2 $0.02 +$0.95 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$3 -$1 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$1 +$2.50 +73.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1 +$2.48 +72.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$3 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$3 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11

Amylyx Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4 -$5 -707% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $0.73 +$4.12 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 -$3 +$9.96 +74.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$13 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.